XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
 9 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating activities    
Net loss $ (7,327) $ (7,868)
Adjustments to reconcile net loss to net cash used in operating activities:    
Share-based compensation 5,381 4,593
Depreciation and amortization 1,223 737
Amortization of purchased intangible assets 4,340 4,112
Amortization of manufacturing profit in acquired inventory associated with acquisitions 181 380
Loss on disposal of property and equipment (10) 3
Amortization of deferred debt issuance costs 77 241
Fair value remeasurement of earnout consideration (533) 2,462
Non-cash loss on extinguishment of debt 0 764
Changes in operating assets and liabilities, net of assets and liabilities acquired:    
Accounts receivable 2,553 (4,518)
Inventories (10,637) (10,657)
Contract manufacturers’ receivable 1,139 (68)
Prepaid expenses and other current assets 2,260 (761)
Lease right-of-use assets 1,332 1,203
Other assets (31) (94)
Accounts payable (5,782) 4,281
Accrued payroll and related expenses (1,918) (1,261)
Other liabilities 6,796 385
Net cash used in operating activities (956) (6,066)
Investing activities    
Purchases of property and equipment (2,325) (1,138)
Cash payment for acquisitions, net of cash and cash equivalents acquired (4,650) (23,629)
Net cash used in investing activities (6,975) (24,767)
Financing activities    
Net proceeds from issuances of common stock 752 33,354
Tax withholding paid on behalf of employees for restricted shares (674) (1,646)
Net proceeds from issuance of debt 4,909 28,800
Payment of borrowings on term loan (1,475) (16,625)
Net proceeds from borrowing on line of credit 2,000 2,500
Payment of borrowings on line of credit (2,000) (2,500)
Net proceeds from public offering 0 0
Payment of lease liabilities (7) (7)
Net cash provided by financing activities 3,505 43,876
Increase (decrease) in cash and cash equivalents (4,426) 13,043
Cash and cash equivalents at beginning of period 17,221 9,739
Cash and cash equivalents at end of period $ 12,795 $ 22,782